arrow
S

Seth J. Zost

Vanderbilt University Medical Center
H指数:31
被引数:8,943

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potently neutralizing and protective human monoclonal antibodies against the measles fusion protein trimer

强效中和及保护性人源单克隆抗体针对麻疹病毒融合蛋白三聚体

2026-09-280
OAAI
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants

以表位为重点的发现可有效中和Omicron变体的SARS-CoV-2抗体

2026-03-120
OAAI
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site

靶向流感A病毒神经氨酸酶活性位点的保护性和异亚型抗体谱系

2025-12-010
PRE
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

来自人类HIV-1疫苗试验参与者的糖链反应性抗体显示出广泛的病原体交叉反应性

2025-11-010
PRE
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice

小鼠适应性SARS-CoV-2 Omicron BA.5感染诱导BALB/c小鼠发生急性后肺纤维化

2025-11-010
PRE
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Nature
IF48.5
2024-05-150
PRE
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
2023-04-016
OAAI
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
2021-10-0125
OAAI
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
2021-09-210
PREAI
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

识别流感血凝素三聚体界面的人类抗体的规范特征

2021-08-0222
OA
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
2021-08-0163
OAAI
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

SARS-CoV-2变体对单克隆和血清衍生多克隆抗体中和的抗性

2021-03-04699
OAAI
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature
IF48.5
2020-07-150
PREAI
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
2020-07-10346
OAAI